Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor (Q27689029)

4

0 references

Yuen Kwok-yung

13

0 references

Lu Lu

object named as

Lu Lu

1

0 references

Shibo Jiang

15

object named as

Shibo Jiang

0 references

Lanying Du

9

object named as

Lanying Du

0 references

author name string

Qi Liu

2

0 references

Yun Zhu

3

0 references

Lili Qin

5

0 references

Yuan Li

6

0 references

Qian Wang

7

0 references

Fei Yu

10

0 references

Cuiqing Ma

11

0 references

Sheng Ye

12

0 references

Rongguang Zhang

Coronavirus as a possible cause of severe acute respiratory syndrome

14

0 references

language of work or name

English

0 references

publication date

2014

0 references

published in

Nature Communications

0 references

volume

5

0 references

issue

1

0 references

page(s)

3067

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Public health: Broad reception for coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Hospital outbreak of Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Family cluster of Middle East respiratory syndrome coronavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Interspecies transmission and emergence of novel viruses: lessons from bats and birds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

HIV-1 inhibition by a peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Core structure of gp41 from the HIV envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Structures and polymorphic interactions of two heptad-repeat regions of the SARS virus S2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Crystal structure of severe acute respiratory syndrome coronavirus spike protein fusion core

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Structure of a proteolytically resistant core from the severe acute respiratory syndrome coronavirus S2 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Central ions and lateral asparagine/glutamine zippers stabilize the post-fusion hairpin conformation of the SARS coronavirus spike glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Core structure of S2 from the human coronavirus NL63 spike glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Structural characterization of the SARS-coronavirus spike S fusion protein core.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Novel therapies based on mechanisms of HIV-1 cell entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Automated selection of stabilizing mutations in designed and natural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Measuring the Strength of Side-Chain Hydrogen Bonds in Peptide Helixes: The Gln.cntdot.Asp (i, i + 4) Interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Design of a novel HIV-1 fusion inhibitor that displays a minimal interface for binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Processing of X-ray diffraction data collected in oscillation mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Coot: model-building tools for molecular graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

PHENIX: a comprehensive Python-based system for macromolecular structure solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Determination of the helix and beta form of proteins in aqueous solution by circular dichroism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Automatic quantitation of HIV-1 mediated cell-to-cell fusion with a digital image analysis system (DIAS): application for rapid screening of HIV-1 fusion inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS4067

Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence

21 January 2018

1 reference

12 December 2020

Determination of the HIV-1 gp41 fusogenic core conformation modeled by synthetic peptides: applicable for identification of HIV-1 fusion inhibitors

1 reference

12 December 2020

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

1 reference

12 December 2020

A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein

1 reference

12 December 2020

Characterization of HCoV-229E fusion core: implications for structure basis of coronavirus membrane fusion

1 reference

12 December 2020

Biochemical and biophysical characterization of the transmissible gastroenteritis coronavirus fusion core

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCOMMS4067

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

ADS bibcode

2014NatCo...5.3067L

0 references

1008179102

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

PMC publication ID

7091805

0 references

PubMed publication ID

24473083

1 reference

Consolidated OpenCitations Corpus – April 2017